Novartis Investigative Site

Cloppenburg 49661

0 studies enrolling now · 2 studies all time

What they study most

Acute Decompensated Heart Failure, Cardiovascular Disease, Congestive Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early
• Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure — Completed